Non-selective NSAIDs deemed acceptable

The European Medicines Agency (EMEA) has concluded the risk-benefit balance for non-selective NSAIDs remains favourable.

Arthitic hand
Arthitic hand
This conclusion has been drawn from the review announced in September of this year [http://www.healthcarerepublic.com/news/Nurse/LatestNews/595593/emea%20to%20review%20non-selective%20nsaids].

The Committee for Medicinal Products for Human Use (CHMP), and committee within the EMEA, concluded that:
  • Non-selective NSAIDs are important treatments for arthritis and other painful conditions.
  • It cannot be excluded that non-selective NSAIDs may be associated with a small increase in the absolute risk for thrombotic events, especially when used at high doses for long-term treatment.
  • The overall benefit-risk balance for non-selective NSAIDs remains favourable when used in accordance with the product information, namely on the basis of the overall safety profile of the respective non-selective NSAID, and taking into account the patient's individual risk factors (for example gastrointestinal, cardiovascular and renal).

The risk-benefit of piroxicam is being assessed separately.

The CHMP confirmed its previous advice that patients should receive the lowest dose of non-selective NSAID, for the shortest duration possible.

MIMS link

Musculoskeletal pain/inflammation 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Former Brexit secretary backs vitamin D supplements to beat COVID-19

Former Brexit secretary backs vitamin D supplements to beat COVID-19

The NHS should provide 10 times the current daily recommended amount of vitamin D...

Identifying patients experiencing domestic violence and abuse in general practice

Identifying patients experiencing domestic violence and abuse in general practice

Dr Vasumathy Sivarajasingam describes a pilot project in her practice that used a...

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

High rates of COVID-19 infection and the impact of long COVID could 'wreak havoc'...

GPs can give COVID and flu jabs at same time, says NHS England

GPs can give COVID and flu jabs at same time, says NHS England

GPs can now administer COVID-19 and flu jabs at the same time, according to updated...

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Regions of England hit hardest by COVID-19 cases have fallen behind the rest of the...

COVID-19 pandemic drives first recorded dip in patients registered with GPs

COVID-19 pandemic drives first recorded dip in patients registered with GPs

A rise in deaths and reduced immigration during the COVID-19 pandemic saw the first-ever...